• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 26 Feb 2025

DRX: Back at It Again; $120M in New Contracts Signed


ADF Group Inc. (DRX:TSE) | 0 0 -1.9% | Mkt Cap: 38.0m


  • Atrium Research
    • Nicholas Cortellucci, CFA

    • 4 pages


 

What you need to know: • ADF Group announced that it has signed $120M in new contracts across Quebec and the U.S., resulting in the pro-forma backlog reaching $450M. • Despite the concerns about tariffs, management was able to execute on its plan to sign new contracts, setting up the Company for a strong 2025. • Since announcing its NCIB, ADF has repurchased 721K shares, representing 2.4% of its shares outstanding. • ADF continues to trade at only 2.6x/3.0x FY25E/FY26E EBITDA. This morning, ADF Group (DRX:TSX, ADFJF:OTC) announced $120M in new contracts in Quebec and the United States, bringing the backlog to $450M. While ADF stock has pulled back significantly on the declining backlog and tariff concerns, this announcement should ease investors and highlight the major tailwinds supporting ADF’s business model. We also provide a preview of the Q4 and FY25 financials which will be released at the end of April. ADF has also been actively buying back stock, having repurchased 721K shares since December (2.4% of its shares outstanding). We are maintaining our BUY rating and $23.00/share target price on ADF Group. Contract Announcement ADF reported that it has signed a series of new contracts in Quebec and the Western U.S., totalling $120M. The largest contract in the group was the fabrication and installation of steel structures and heavy steel components for a major renovation program for a sports complex in the Western United States. The other orders were various structural steel contracts in the recreational sector, also in the Western U.S. and in Quebec for a major client which ADF has previously completed other work for. Both of ADF’s fabrication facilities will be utilized to complete the orders over the coming 15 months. The backlog was last reported at $330.3M as of October 2024, and adjusting for today’s release, the pro-forma backlog is $450.3M. This is the highest the backlog has been since fiscal Q1/25. We remind readers that >80% of the backlog is typically converted into sales over 15 months. We will also reiterate that management has executed on exactly what they said they would do on the Q3 conference call, building our confidence further.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

DRX: Back at It Again; $120M in New Contracts Signed


ADF Group Inc. (DRX:TSE) | 0 0 -1.9% | Mkt Cap: 38.0m


  • Published: 26 Feb 2025
  • Author: Nicholas Cortellucci, CFA
  • Pages: 4
  • Atrium Research


What you need to know: • ADF Group announced that it has signed $120M in new contracts across Quebec and the U.S., resulting in the pro-forma backlog reaching $450M. • Despite the concerns about tariffs, management was able to execute on its plan to sign new contracts, setting up the Company for a strong 2025. • Since announcing its NCIB, ADF has repurchased 721K shares, representing 2.4% of its shares outstanding. • ADF continues to trade at only 2.6x/3.0x FY25E/FY26E EBITDA. This morning, ADF Group (DRX:TSX, ADFJF:OTC) announced $120M in new contracts in Quebec and the United States, bringing the backlog to $450M. While ADF stock has pulled back significantly on the declining backlog and tariff concerns, this announcement should ease investors and highlight the major tailwinds supporting ADF’s business model. We also provide a preview of the Q4 and FY25 financials which will be released at the end of April. ADF has also been actively buying back stock, having repurchased 721K shares since December (2.4% of its shares outstanding). We are maintaining our BUY rating and $23.00/share target price on ADF Group. Contract Announcement ADF reported that it has signed a series of new contracts in Quebec and the Western U.S., totalling $120M. The largest contract in the group was the fabrication and installation of steel structures and heavy steel components for a major renovation program for a sports complex in the Western United States. The other orders were various structural steel contracts in the recreational sector, also in the Western U.S. and in Quebec for a major client which ADF has previously completed other work for. Both of ADF’s fabrication facilities will be utilized to complete the orders over the coming 15 months. The backlog was last reported at $330.3M as of October 2024, and adjusting for today’s release, the pro-forma backlog is $450.3M. This is the highest the backlog has been since fiscal Q1/25. We remind readers that >80% of the backlog is typically converted into sales over 15 months. We will also reiterate that management has executed on exactly what they said they would do on the Q3 conference call, building our confidence further.

More Content

More Content

DRX: Record FY Financials; Lowering Estimates on Tariff Impacts

Companies: ADF Group Inc.

Atrium Research

Small-Caps with Torque to Infrastructure Spending

Companies: DRX CEMX QTRH GRID

Atrium Research

Q1/25 Recap: All Our Research in One Place!

Companies: NIM SCZ DRX AUAU ARG OMG BQE DNG EDG KNR MOO NIM RIO SBIO LVG TOC TM SCZ CAPT GIGA APM FISH

Atrium Research

DRX: Value Stock Entering Multi-Year Growth Cycle

Companies: ADF Group Inc.

Atrium Research

Finding the Next Takeout in Canadian Small-Caps - Part Four

Companies: GSI KUT IFX QIS HAI DRX BQE GCL COV CTX FTG GSI IFX PNG MAL NPTH QIS GRID SYZ VLN COV ETOLF

Atrium Research
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Acquisdata
      • Actinver
      • Actio Advisors
      • Asset TV
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Brand Communications
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD (hosted by Progressive)
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In